Ocular Trauma Devices Market Size, Growth, Trends | Report 2022-2030
The global ocular trauma devices market was surpassed at USD 3.61 billion in 2021 and is expected to hit around USD 6.7 billion by 2030, growing at a CAGR of 7.11% from 2022 to 2030.
Report Highlights
Ocular trauma is sometimes referred to as non-penetrating trauma or blunt force trauma to the eye area. Combinations of forces, including acceleration and deceleration, shearing, and crushing pressure can result in ocular trauma. Ocular trauma can cause damage to the eye, the eyelid, and the surrounding bones resulting in blunt eye injuries such as globe exploding, retinal separation, hyphemia, frontal eye hemorrhage, retrobulbar hemorrhage, fracture of the orbit, accidental glaucoma, vitreous bleeding, corneal injuries, and cataract. According to a report by the vision center, around 95% of ocular trauma occurs in men under the age of 30, often caused by interpersonal violence.
Healthcare delivery was severely damaged due to the COVID-19 pandemic. Despite an overwhelming number of COVID-19 cases, ophthalmic clinics witnessed a sharp reduction in outpatient visits and operations, and hospitals lost a large amount of revenue in the initial stage of the pandemic. The COVID-19 pandemic had a negative effect on the sales of ocular devices such as contact lenses, implants, and ocular instruments. Ophthalmic clinics stayed closed throughout the lockdown period since ophthalmologists and healthcare professionals faced the biggest risk of spreading the virus. As a result, there was a decrease in the demand for ocular care products. However, the market is expected to regain its pre-pandemic position in the coming years due to the relaxation of regulations at present and the considerable economic recovery.
Several organizations along with ophthalmologists have launched campaigns and initiatives to increase awareness about ocular care and eye health among the general public. These organizations provide seminars, tutorials, and workshops that teach technicians how to utilize different pieces of ophthalmic equipment. Such programs aid in raising awareness of eye conditions and the availability of diagnostic tools.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 3.61 billion |
| Revenue Forecast by 2030 | USD 6.7 billion |
| Growth rate from 2022 to 2030 | CAGR of 7.11% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Device type, indication, end-use, region |
| Companies Covered |
Alcon, Bausch & Lomb, Inc., Carl Zeiss AG, Johnson & Johnson Vision, CooperVision, TopCon, EssilorLuxottica, Hoya Corporation, Glaukos Corporation |
Device Type Insights
Based on device type, the market is segmented into implants, instruments, and disposables. Among these, the implants segment accounted for the largest market share of 45.05% in 2021 and is expected to witness the fastest CAGR of 8.11% over the forecast period from 2022 to 2030. The rising incidence of eye-related disorders & injuries such as age-related macular degeneration, cataract, glaucoma, and scleritis is expected to contribute to the growing demand for ocular trauma devices.
The International Diabetes Federation estimates that 643 million people will have diabetes by 2030, up from an estimated 537 million in 2021. The rising prevalence of diabetes across the globe and the growing adoption of a sedentary lifestyle is likely to increase the risk of diabetic retinopathy in the coming years. The rising cases of diabetic retinopathy are likely to increase the demand for ocular trauma devices such as implants and disposables.
Indication Insights
Based on the indication, the market is segmented into blunt trauma, chemical trauma, and sharp trauma. The blunt trauma segment dominated the market with a revenue share of 47.54% in 2021. Combinations of forces such as acceleration and deceleration, shearing, & crushing pressure can result in blunt trauma to the eye area. Blunt eye injury describes an injury or a wound in the vicinity of the eye brought on by a strong blow or a physical assault with a dull instrument. The WHO projects that there will be over 2 billion elderly people worldwide by 2050. The rising elderly population will fuel the expansion of the segment growth across the globe.
On the other hand, the sharp trauma segment is expected to witness the fastest growth during the forecast period with a CAGR of 8.74% owing to the growing cases of sharp object eye injuries, especially in the workplace environment. According to the U.S. Bureau of labor safety, the majority of occupational injuries in the U.S. are caused due to sharp objects, slips, trips, falls, and contact with sharp items & equipment.
End-Use Insights
Based on end-use, the market is segmented into hospitals, ophthalmic clinics, and others. Among these, the hospital segment dominated the market in terms of revenue share in 2021 with a share of 50.31% owing to the growing use of ophthalmic technology and the availability of affordable and efficient treatment in the hospitals. In the upcoming years, the need for new device installations is projected to increase due to the rising number of collaborations between ophthalmic clinics and hospitals due to more patients choosing to have ocular procedures performed in hospitals instead of clinics.
The ophthalmic clinics segment is expected to witness the fastest growth during the forecast period with a CAGR of 7.92% from 2022 to 2030. Due to the increasing need for eye care services in outlying locations, the ophthalmic clinic segment is anticipated to expand significantly over the forecast period. With a sharp increase in the number of specialty ophthalmic centers, it is projected that the growing number of ophthalmologists in developing economies will have a significant impact on segment growth.
Regional Insights
In 2021, North America accounted for the largest revenue share of 43.83% due to the rise in the elderly population, increased cases of eye-related problems, and an overall increase in healthcare costs. Moreover, factors such as high levels of stress, poor lifestyles, and the increased frequency of chronic eye disorders such as diabetic retinopathy are contributing to market growth.
Asia Pacific is anticipated to witness rapid growth over the forecast period with a CAGR of 9.62% pertaining to the significant rise in the aging population along with the improving healthcare infrastructure. In addition, developing nations such as China and India are expected to have the highest development in healthcare delivery. The market in this region is expanding due to the rising diabetic population, growing cataract procedures, and the rising costs of both private & public eye care.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ocular Trauma Devices Market
5.1. COVID-19 Landscape: Ocular Trauma Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ocular Trauma Devices Market, By Device Type
8.1. Ocular Trauma Devices Market, by Device Type, 2022-2030
8.1.1 Implants
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Disposables
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Ocular Trauma Devices Market, By Indication
9.1. Ocular Trauma Devices Market, by Indication, 2022-2030
9.1.1. Blunt Trauma
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Chemical Trauma
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Sharp Trauma
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Ocular Trauma Devices Market, By End-Use
10.1. Ocular Trauma Devices Market, by End-Use, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Ophthalmic Clinics
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Ocular Trauma Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Indication (2017-2030)
11.1.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Indication (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Indication (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Indication (2017-2030)
11.2.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Indication (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Indication (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Indication (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Indication (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Indication (2017-2030)
11.3.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Indication (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Indication (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Indication (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Indication (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Indication (2017-2030)
11.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Indication (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Indication (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Indication (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Indication (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Indication (2017-2030)
11.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Indication (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Device Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Indication (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 12. Company Profiles
12.1. Alcon
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bausch & Lomb, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Carl Zeiss AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Johnson & Johnson Vision
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. CooperVision
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. TopCon
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. EssilorLuxottica
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Hoya Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Glaukos Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers